Atossa Therapeutics
ATOS
#9336
Rank
A$0.13 B
Marketcap
A$1.07
Share price
-1.90%
Change (1 day)
-33.04%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -A$46.92 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$38.09 Million, an increase over its 2023 earnings that were of -A$44.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$46.92 Million23.21%
2024 -A$38.09 Million-15.25%
2023 -A$44.94 Million11.62%
2022 -A$40.26 Million30.84%
2021 -A$30.77 Million15.58%
2020 -A$26.62 Million3.41%
2019 -A$25.75 Million51.16%
2018 -A$17.03 Million40.41%
2017 -A$12.13 Million27.54%
2016 -A$9.51 Million-47.49%
2015 -A$18.11 Million-17.25%
2014 -A$21.89 Million35.91%
2013 -A$16.11 Million112.3%
2012 -A$7.59 Million46.53%
2011 -A$5.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.37 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$1.99 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.92 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-A$11.71 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$62.23 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-A$0.17 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA